A detailed history of Kingsview Wealth Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 27,124 shares of EW stock, worth $1.81 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
27,124
Previous 26,878 0.92%
Holding current value
$1.81 Million
Previous $2.57 Million 2.45%
% of portfolio
0.06%
Previous 0.07%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $20,737 - $23,200
246 Added 0.92%
27,124 $2.51 Million
Q1 2024

May 09, 2024

SELL
$72.54 - $95.56 $7,689 - $10,129
-106 Reduced 0.39%
26,878 $2.57 Million
Q4 2023

Feb 08, 2024

BUY
$61.71 - $77.76 $7,034 - $8,864
114 Added 0.42%
26,984 $2.06 Million
Q3 2023

Nov 07, 2023

BUY
$69.28 - $93.38 $36,302 - $48,931
524 Added 1.99%
26,870 $1.86 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $40,323 - $45,888
-543 Reduced 2.02%
26,346 $2.18 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $8,469 - $10,842
-124 Reduced 0.46%
26,889 $2.01 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $2,388 - $3,111
29 Added 0.11%
27,013 $2.23 Million
Q2 2022

Aug 16, 2022

SELL
$86.5 - $128.27 $58,387 - $86,582
-675 Reduced 2.44%
26,984 $2.57 Million
Q1 2022

Feb 08, 2024

BUY
$101.96 - $128.34 $35,686 - $44,919
350 Added 1.3%
27,334 $3.22 Million
Q4 2021

Feb 17, 2022

BUY
$106.37 - $130.68 $85,096 - $104,544
800 Added 2.98%
27,659 $3.58 Million
Q3 2021

Dec 03, 2021

BUY
$102.91 - $122.75 $121,948 - $145,458
1,185 Added 4.62%
26,859 $3.04 Million
Q2 2021

Aug 17, 2021

SELL
$83.84 - $104.76 $51,980 - $64,951
-620 Reduced 2.36%
25,674 $2.69 Million
Q1 2021

May 24, 2021

SELL
$78.68 - $90.67 $9,756 - $11,243
-124 Reduced 0.47%
26,294 $2.2 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $134,490 - $171,147
-1,876 Reduced 6.63%
26,418 $2.41 Million
Q3 2020

Nov 19, 2020

BUY
$67.19 - $87.44 $49,048 - $63,831
730 Added 2.65%
28,294 $2.26 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $991,989 - $1.33 Million
17,240 Added 166.99%
27,564 $1.91 Million
Q1 2020

May 11, 2020

BUY
$52.41 - $81.0 $260,896 - $403,218
4,978 Added 93.12%
10,324 $1.95 Million
Q4 2019

Jan 31, 2020

BUY
$71.7 - $82.09 $383,308 - $438,853
5,346 New
5,346 $1.25 Million
Q3 2019

Jan 29, 2020

SELL
$61.55 - $75.43 $170,801 - $209,318
-2,775 Closed
0 $0
Q2 2019

Jan 29, 2020

SELL
$55.74 - $64.41 $2,787 - $3,220
-50 Reduced 1.77%
2,775 $513,000
Q1 2019

Jan 29, 2020

SELL
$47.89 - $64.05 $31,128 - $41,632
-650 Reduced 18.71%
2,825 $541,000
Q4 2018

Jan 29, 2020

SELL
$46.41 - $56.94 $4,641 - $5,694
-100 Reduced 2.8%
3,475 $532,000
Q1 2018

Jan 29, 2020

BUY
$37.19 - $47.45 $132,954 - $169,633
3,575 New
3,575 $520,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.2B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.